Biotech News

US stocks were set for a flat open on Tuesday after a slight decline in the prior session left the S&P 500 within striking distance of its recent record high and amid investor caution as tensions in Ukraine continued.

When President Bill Clinton announced in 2000 that Craig Venter and Dr. Francis Collins of the National Human Genome Research Institute had succeeded in mapping the human genome, he solemnly declared that the discovery would "revolutionize" the treatment of virtually all human disease.

While superficial evidence of a bubble exists, I believe a deeper look at the issue reveals that such talk is premature.

Medical-device companies have been largely left out of the past year's parade of biotech businesses onto the public markets, yet on Monday two companies selling devices to treat the very same ailment filed their initial public offering paperwork.

La Jolla Pharmaceutical Co said its experimental drug to treat chronic kidney disease met the main goal of improving kidney function in a mid-stage study.

Conversations with clients this week revealed that many investors are also weighing mixed feelings about valuation and the potential for growth.

Discouraging economic news from China and Japan stoked investors' worries about a global slowdown, sending U.S. stocks lower Monday.

Based on the way they are betting their million-dollar-a-year jobs and the firm's capital in multi-million dollar lumps.

ZENBU, a new, freely available bioinformatics tool enables researchers to quickly and easily integrate, visualize and compare large amounts of genomic information resulting from large-scale, next-generation sequencing experiments.

GlaxoSmithKline has lifted its stake in the group's Indian subsidiary to 75 percent, the British drugmaker said on Monday.

Suicide is the third leading cause of death among teens 15 to 19 years old, according to the National Centers for Disease Control and Prevention.

Robert W. Baird's target price would indicate a potential downside of 3.97% from the company's current price.

Washington, March 9 : Researchers have now reported their development of new methods and techniques for engineering lungs for patients with COPD and pulmonary fibrosis.

At 46 years old, Zbigniew Kacprzyk thought that he was all set with a career. Punch in, punch out and stow away the nickels for retirement.

Dr. Marcus Plescia, Mecklenburg County's new health director, is following in the footsteps of his grandfather, who was a physician in England, and his uncle, a Catholic priest in Italy who cared for the spiritual needs of infirmed elderly villagers.

Stocks ended mixed Friday, as the enthusiasm following a better-than-expected jobs report wore off.

Jackalina Van Kampen, director of preclinical research at Neurodyn Inc. in Charlottetown, says women continue to face barriers in trying to break into the biotechnology field.

A woman on board a Delta flight from New York to San Diego fell unconscious on the plane when a passenger sprung into action to help.

Ranbaxy recalled tablets of atorvastatin calcium, the generic version of Pfizer's cholesterol fighter Lipitor, after a pharmacist found a 20-milligram tablet in a sealed bottle marked for 10-milligram tablets, the US Food and Drug Administration said on its website.

The event will benefit ISC's educ... As the Mining Industry Heads Home from PDAC, Here Are Five Things They Need to Keep in Mind for the Year Ahead )--The mining industry is not for the faint of heart- risk is part of doing business.